Molina-Ruiz Ana María, Lasanta Begoña, Barcia Ana, Pérez-Vega Elisa, Requena Luis
Department of Dermatology, Fundación Jiménez Díaz, Madrid, Spain.
Department of Dermatology, Hospital San Agustín, Seville, Spain.
Australas J Dermatol. 2017 Feb;58(1):e20-e22. doi: 10.1111/ajd.12393. Epub 2015 Sep 30.
Drug-induced lupus erythematosus (DILE) is a less severe variant of systemic lupus erythematosus (SLE) that generally resolves within weeks or months after the withdrawal of the implicated drug. DILE is unusual during childhood, with the most frequent age of presentation being at 50-70 years of age. Among different drugs, most commonly procainamide and hydralazine have been implicated as a cause of DILE. However carbamazepine (CBZ) is considered a low-risk drug and very few cases have been reported in children. We describe the case of CBZ-induced SLE in a 9-year-old girl following 3 years of CBZ therapy. This case report shows that drug-induced SLE is an important side-effect to be considered, even after long-term treatment with CBZ, and also during childhood.
药物性红斑狼疮(DILE)是系统性红斑狼疮(SLE)的一种症状较轻的变体,通常在停用相关药物后的数周或数月内消退。DILE在儿童期并不常见,最常见的发病年龄为50至70岁。在不同药物中,最常被认为是DILE病因的是普鲁卡因胺和肼屈嗪。然而,卡马西平(CBZ)被认为是一种低风险药物,儿童中报道的病例很少。我们描述了一名9岁女孩在接受3年CBZ治疗后发生CBZ诱导的SLE的病例。本病例报告表明,即使经过长期CBZ治疗,甚至在儿童期,药物性SLE也是一个需要考虑的重要副作用。